1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Rodríguez-Goncer I, Ruiz-Arabi E, Herrera S, Sabé N, Los-Arcos I, Silva JT, Pérez-Nadales E, Machuca I, Álvarez R, Valerio M, Castón JJ, Aguilera V, Bodro M, Cano Á, Cantón R, Carmona P, Carratalà J, Cordero E, Cruzado JM, Fariñas MC, Fernández-Ruiz M, Fondevila C, Fortún J, García-Cosío MD, Gutiérrez-Dalmau A, Iturbe D, Justo I, Len O, López-Medrano F, López Oliva MO, Martín-Dávila P, Martínez-Martínez L, Mazuecos A, Mirabet S, Muñoz P, Oliver A, Pérez-Sáez MJ, Rodríguez-Gómez J, San-Juan R, Sánchez-Céspedes J, Solé A, Vidal Verdú E, Villa J, Torre-Cisneros J, Aguado JM.

    Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

    TRANSPLANTATION REVIEWS . 39(3): 100937-100937.

    [doi:10.1016/j.trre.2025.100937]

  • Ollero MJF, Ryan P, Dolengevich-Segal H, Cano-Smith J, Ramos-Ruperto L, Cabello A, Sanchez-Conde M, Cabello N, Sanz J, García-Fraile LJ, Perez-Latorre L, Bisbal O, De La Fuente S, Losa JE, González-Baeza A.

    Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors.

    AIDS AND BEHAVIOR . 29(7): 2324-2335.

    [doi:10.1007/s10461-025-04695-x]

  • de Luque CMC, Sánchez-Conde M, Brañas F.

    Nonpharmacologic interventions to improve quality of life of older adults with HIV.

    CURRENT OPINION IN HIV AND AIDS . 20(4): 402-408.

    [doi:10.1097/COH.0000000000000937]

  • Yuste E, Ruiz-de-León MJ, Casado JL, Moreno A, Vivancos MJ, Pérez-Elías MJ, Dronda F, Quereda C, Sánchez-Merino V, Vallejo A.

    Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution.

    Vaccines . 13(6): .

    [doi:10.3390/vaccines13060639]

  • Sastre-Escolà E, Ntziora F, Chiurlo M, Martín-Dávila P, Mikulska M, Albasanz-Puig A, Machado M, Gutiérrez-Villanueva A, Márquez-Gómez I, Gasch-Blasi O, Sipsas NV, Oltolini C, Fortún J, Ruiz-Camps I, Fernández-Cruz A, Peña M, Laporte-Amargos J, Bergas A, Badia-Tejero AM, Carratalà J, Gudiol C.

    Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenemase-producing Enterobacterales in onco-haematologic neutropenic patients (the TARZAN study).

    The Journal of antimicrobial chemotherapy . 80(6): 1673-1681.

    [doi:10.1093/jac/dkaf120]

  • Fra S, Muñoz-Molina GM, Cano JR, Cabañero A, Caballero U, Cobo J, Monopoli D, Mentado B, Moreno N.

    Innovative posterior chest wall reconstruction with vertebra-fixed custom-made prosthesis.

    Jtcvs Techniques . 31: 199-202.

    [doi:10.1016/j.xjtc.2025.03.025]

  • Fortún J, Rodríguez-Gandía MA, Pintado V, Martín-Dávila P, García-González M, Graus J, Martín-Mateos R, Fuente JS, Muriel A, Moreno S.

    Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study.

    Infection . 53(3): 1219-1225.

    [doi:10.1007/s15010-025-02491-2]

  • Heyer R, Wolf M, Benndorf D, Uzzau S, Seifert J, Grenga L, Pabst M, Schmitt H, Mesuere B, Van Den Bossche T, Haange SB, Jehmlich N, Di Luca M, Ferrer M, Serrano-Villar S, Armengaud J, Bode HB, Hellwig P, Masselot CR, Léonard R, Wilmes P.

    Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomes.

    Microbiome . 13(1): 134-134.

    [doi:10.1186/s40168-025-02119-5]

  • Gayoso-Cantero D, Corbacho-Loarte MD, Crespillo-Andújar C, Chamorro-Tojeiro S, Norman F, Perez-Molina JA, González-Sanz M, Martín O, Rubio JM, Gullón-Peña B, Del Campo Albendea L, López-Vélez R, Monge-Maillo B.

    Changes in Lipid Profile Secondary to Asymptomatic Malaria in Migrants from Sub-Saharan Africa: A Retrospective Analysis of a 2010-2022 Cohort.

    Tropical Medicine and Infectious Disease . 10(5): .

    [doi:10.3390/tropicalmed10050134]

  • Guevara-Hernández P, Llenas-García J, Díaz-Menéndez M, Serre-Delcor N, Crespillo-Andújar C, Salvador F, Ruiz-Giardin JM, Goikoetxea-Agirre J, Torrús-Tendero D, de la Calle-Prieto F, Oliveira-Souto I, Bosch-Nicolau P, Wikman P, Pérez-Molina JA.

    Imported fever in returning travellers and migrants in Spain, 2009-2021. Analysis by the +REDIVI network.

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 65: 102833-102833.

    [doi:10.1016/j.tmaid.2025.102833]

  • Bosch-Nicolau P, Herrero-Martínez JM, Arsuaga M, Chamorro-Tojeiro S, Carrillo I, Bea-Serrano C, Llenas-García J, Pérez-Recio S, Fernández-Pedregal E, Crespillo-Andújar C, Silgado A, Pérez-Ayala A, de la Calle-Prieto F, Prieto-Pérez L, Pérez-Molina JA, Molina I.

    The Chagas non-endemic (ChaNoE) cohort: Aims and study protocol.

    Plos One . 20(4): .

    [doi:10.1371/journal.pone.0320637]

  • Rosas Cancio-Suárez M, Moreno A, del Campo Terrón S, Vivancos MJ, G García-Ruiz De Morales A, Martínez-Sanz J, Ron R, Sánchez-Izquierdo S, Vélez-Díaz-Pallarés M, Moreno S, Pérez-Elías MJ.

    Real-world efficacy and tolerability of CAB+RPV LA in women: addressing the gender gap in HIV treatment research.

    The Journal of antimicrobial chemotherapy . 80(4): 1084-1088.

    [doi:10.1093/jac/dkaf038]

  • Izquierdo R, Suárez-García I, Marco-Sánchez C, Pérez-Latorre L, Riera M, Cano J, Viladés C, Reus S, Olalla J, González-Ruano P, Orviz E, Díaz A, Moreno S, Jarrín I.

    Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time.

    HIV MEDICINE . 26(4): 606-620.

    [doi:10.1111/hiv.13762]

  • Monge-Maillo B, Roger-Zapata D, Dronda F, Carrillo E, Moreno J, Corbacho-Loarte MD, Gayoso Cantero D, Martín O, Chamorro-Tojeiro S, Perez-Molina JA, Norman F, González-Sanz M, López-Vélez R.

    Case Report: Long-Term Follow-Up of Visceral Leishmaniasis and HIV Coinfected Patients Without Relapse: Lymphoproliferative Response After Stimulation with Soluble Leishmania Antigen.

    Microorganisms . 13(3): .

    [doi:10.3390/microorganisms13030686]

  • Bailón L, Moltó J, Curran A, Cadiñanos J, Carlos Lopez Bernaldo de Quirós J, de Los Santos I, Ambrosioni J, Imaz A, Benet S, Suanzes P, Navarro J, González-García J, Busca C, Pérez-Latorre L, Berenguer J, García-Fraile LJ, Mejía-Abril G, Miró JM, Scévola S, Moreno S, Domingo P, Tian Y, Frankot M, Lim D, Cai Y, Vendrame E, Guo S, Wallin JJ, Geleziunas R, SenGupta D, Alarcón-Soto Y, Leal I, Aranguen A, Garcia-Garcia M, McGowan I, Brander C, Arribas JR, Mothe B.

    Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.

    NATURE COMMUNICATIONS . 16(1): 2146-2146.

    [doi:10.1038/s41467-025-57284-w]

  • Cuervo G, Hernández-Meneses M, de Alarcón A, Luque-Marquez R, Alonso-Socas MM, López-Lirola A, González-Ramallo V, Goikoetxea-Agirre AJ, Nicolás D, Goenaga MA, Merino E, Escrihuela-Vidal F, Martín-Dávila P, Loeches B, Boix-Palop L, Gasch O, Camprecios M, Hernández-Torres A, García-Álvarez L, Pajarón M, Ribas MA, Blanes-Hernández R, López-Montesinos I, López-Cortés LE, Vidal B, Fernández-Pittol M, Navarro D, Moreno A, Sala C, Ambrosioni J, Miró JM.

    Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial.

    Infectious diseases and therapy . 14(3): 643-655.

    [doi:10.1007/s40121-025-01110-9]

  • Aslan AT, Kara E, Köksal G, Bilir Y, Saraçoglu KT, Eser F, Güner R, Alkan S, D'Avino A, Escudero-Sanchez R, Kutluca K, Kaya SY, Saltoglu N, Loiacono L, Coladonato S, Giacomo PD, Cascio A, Pallotto C, Francisci D, Öztürk B, Pinar A, Dag O, Harris PNA, Paterson DL, Akova M.

    Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study.

    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . 65(3): 107446-107446.

    [doi:10.1016/j.ijantimicag.2025.107446]

  • Norman FF, Arce OA, Díaz-Menéndez M, Belhassen-García M, González-Sanz M.

    Changes in the epidemiology of Crimean-Congo hemorrhagic fever: Impact of travel and a One Health approach in the European region.

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 64: 102806-102806.

    [doi:10.1016/j.tmaid.2025.102806]